| Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study J Albores‐Saavedra, K Batich, F Chable‐Montero, N Sagy, AM Schwartz, ... Journal of cutaneous pathology 37 (1), 20-27, 2010 | 647 | 2010 |
| Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients DA Mitchell, KA Batich, MD Gunn, MN Huang, L Sanchez-Perez, SK Nair, ... Nature 519 (7543), 366-369, 2015 | 560 | 2015 |
| The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists S Thomas, J Izard, E Walsh, K Batich, P Chongsathidkiet, G Clarke, ... Cancer research 77 (8), 1783-1812, 2017 | 376 | 2017 |
| Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program J Albores‐Saavedra, AM Schwartz, K Batich, DE Henson Journal of surgical oncology 100 (7), 598-605, 2009 | 339 | 2009 |
| Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination KA Batich, EA Reap, GE Archer, L Sanchez-Perez, SK Nair, ... Clinical Cancer Research 23 (8), 1898-1909, 2017 | 278 | 2017 |
| Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3 TH Schaller, KA Batich, CM Suryadevara, R Desai, JH Sampson Expert review of clinical immunology 13 (11), 1049-1060, 2017 | 116 | 2017 |
| Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End … J Albores-Saavedra, K Batich, S Hossain, DE Henson, AM Schwartz Annals of diagnostic pathology 13 (6), 378-383, 2009 | 113 | 2009 |
| Dendritic cells enhance polyfunctionality of adoptively transferred T cells that target cytomegalovirus in glioblastoma EA Reap, CM Suryadevara, KA Batich, L Sanchez-Perez, GE Archer, ... Cancer research 78 (1), 256-264, 2018 | 104 | 2018 |
| Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma CM Suryadevara, R Desai, ML Abel, KA Riccione, KA Batich, SH Shen, ... Oncoimmunology 7 (6), e1434464, 2018 | 94 | 2018 |
| Once, twice, three times a finding: reproducibility of dendritic cell vaccine trials targeting cytomegalovirus in glioblastoma KA Batich, DA Mitchell, P Healy, JE Herndon, JH Sampson Clinical Cancer Research 26 (20), 5297-5303, 2020 | 80 | 2020 |
| Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses MN Huang, LT Nicholson, KA Batich, AM Swartz, D Kopin, S Wellford, ... The Journal of clinical investigation 130 (2), 774-788, 2020 | 58 | 2020 |
| Emerging immunotherapies for glioblastoma R Desai, CM Suryadevara, KA Batich, SH Farber, L Sanchez-Perez, ... Expert opinion on emerging drugs 21 (2), 133-145, 2016 | 51 | 2016 |
| Peptide vaccines for the treatment of glioblastoma AM Swartz, KA Batich, PE Fecci, JH Sampson Journal of neuro-oncology 123, 433-440, 2015 | 47 | 2015 |
| Operative and peri‐operative considerations in the management of brain metastasis EW Sankey, V Tsvankin, MM Grabowski, G Nayar, KA Batich, A Risman, ... Cancer medicine 8 (16), 6809-6831, 2019 | 44 | 2019 |
| Immunotherapy is changing first-line treatment of metastatic renal-cell carcinoma MK Labriola, KA Batich, J Zhu, MA McNamara, MR Harrison, ... Clinical genitourinary cancer 17 (3), e513-e521, 2019 | 38 | 2019 |
| Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma KA Batich, AM Swartz, JH Sampson Expert opinion on biological therapy 15 (1), 79-94, 2015 | 30 | 2015 |
| Mucin-containing Rokitansky-Aschoff sinuses with extracellular mucin deposits simulating mucinous carcinoma of the gallbladder J Albores-Saavedra, C Galliani, F Chable-Montero, K Batich, DE Henson The American journal of surgical pathology 33 (11), 1633-1638, 2009 | 21 | 2009 |
| Designing clinical trials for combination immunotherapy: a framework for glioblastoma K Singh, KA Batich, PY Wen, AC Tan, SJ Bagley, M Lim, M Platten, ... Clinical Cancer Research 28 (4), 585-593, 2022 | 20 | 2022 |
| Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens KA Batich, JH Sampson Expert opinion on pharmacotherapy 15 (14), 2047-2061, 2014 | 20 | 2014 |
| Recurrent extradural myxopapillary ependymoma with oligometastatic spread KA Batich, RF Riedel, JP Kirkpatrick, BC Tong, WC Eward, CL Tan, ... Frontiers in Oncology 9, 1322, 2019 | 17 | 2019 |
